Encompass Health Corp (NYSE: EHC) has reported earnings for its third fiscal quarter (ending September 30) of $1.09 versus $0.86 for the same period a year ago — an increase of 27%. E.P.S. were $4.32 for the latest four quarters through September 30 versus $3.59 for the same period a year ago — an increase of 20%.
Recent Price Action
On 10/28/24, Encompass Health Corp (NYSE: EHC) stock declined slightly by -0.4%, closing at $93.09. Moreover, exceptionally high trading volume at 237% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -4.2% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, EHC is expected to continue to be a major Value Builder.
Encompass Health has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Encompass Health has a poor Appreciation Score of 19 but a very high Power Rating of 88, producing the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment